Hui W, Gao Z, Zhu M, Wu H, et al. Reply to "Matters arising: cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach". BMC Cancer 2024;24:881.
PMID: 39039454